Cleared Special

K071185 - MODIFICATION TO: AMBU NEUROLINE, DISPOSABLE MONOPOLAR NEEDLE ELECTRODE (FDA 510(k) Clearance)

May 2007
Decision
30d
Days
Class 2
Risk

K071185 is an FDA 510(k) clearance for the MODIFICATION TO: AMBU NEUROLINE, DISPOSABLE MONOPOLAR NEEDLE ELECTRODE. This device is classified as a Electrode, Needle (Class II - Special Controls, product code GXZ).

Submitted by Ambu A/S (Glen Burnie, US). The FDA issued a Cleared decision on May 30, 2007, 30 days after receiving the submission on April 30, 2007.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1350.

Submission Details

510(k) Number K071185 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 30, 2007
Decision Date May 30, 2007
Days to Decision 30 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GXZ — Electrode, Needle
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1350